Terms: = Endocrine gland cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659 AND Diagnosis
4 results:
1. First-time postmenopausal bleeding as a clinical marker of long-term cancer risk: A Danish Nationwide Cohort Study.
Bengtsen MB; Veres K; Nørgaard M
Br J Cancer; 2020 Feb; 122(3):445-451. PubMed ID: 31806879
[TBL] [Abstract] [Full Text] [Related]
2. Radiographic and Hormonal Regression in Prolactinomas: An Analysis of Treatment Failure.
Akinduro OO; Lu VM; Izzo A; De Biase G; Vilanilam G; Van Gompel JJ; Bernet V; Donaldson A; Olomu O; Meyer FB; Quinones-Hinojosa A; Chaichana KL
World Neurosurg; 2019 Sep; 129():e686-e694. PubMed ID: 31181361
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological significance of dek overexpression in serous ovarian tumors.
Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z
Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407
[TBL] [Abstract] [Full Text] [Related]
4. Follicular variant of papillary thyroid carcinoma: clinical-pathological characterization and long-term follow-up.
Hagag P; Hod N; Kummer E; Cohenpour M; Horne T; Weiss M
Cancer J; 2006; 12(4):275-82. PubMed ID: 16925971
[TBL] [Abstract] [Full Text] [Related]
